• Our Experience

Dermatology

Acne

• A Phase II randomized, double-blind, placebo-controlled, parallel-group, multi-center study of an oral medication used to treat moderate to severe facial acne vulgaris

Atopic Dermatitis

• A Phase I open-label study of the tolerance and pharmacokinetics of a topical agent in healthy volunteers and patients with mild to moderate atopic dermatitis

• A Phase II randomized, double-blind, placebo controlled, parallel-group, multi-center study of a topical agent used in treatment of mild to moderate atopic dermatitis in adults

• A Phase II randomized, double-blind, placebo controlled, parallel-group, multi-center study of a topical agent used in treatment of mild to moderate atopic dermatitis in pediatric and adolescent subjects

• Two Phase II open-label, multi-center, treatment continuation studies in patients with mild to moderate atopic dermatitis

Psoriasis

• An open-label, multi-center chronic plaque psoriasis study to evaluate the safety and tolerability of inter-muscular administration

• A Phase I bioequivalence study in plaque psoriasis